RYR1 p.Pro4489Ser
c.13465C>T · rs781766697 · VCV965229
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0807 | likely benign |
|---|---|---|
| REVEL | 0.276 | benign-leaning |
| SaProt | — | not scored · why |
| ⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 2.8 | GERP 1.7, phastCons 1 |
| Regional constraint | o/e 0.99 | unconstrained · MANE · 22 kb · p 0.81 · regional, not allelic |
| Overall | ||
| CADD | 12.42 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00644% | 15,538 |
| European (non-Finnish)grpmax | 0.00314% | 31,803 |
| African / African-American | 0.00134% | 74,836 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- RYR1
- Protein
- p.Pro4489Ser
- Coding
- c.13465C>T
- MANE Select
- NM_000540
- dbSNP
- rs781766697
- Type
- single nucleotide variant
- Location
- chr19:38566938 (GRCh38)
- Gene constraint
- LOEUF 0.644 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Residue 4489
- the 'disordered' region
Disease context
RYR1-related disorder — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: central core myopathymalignant hyperthermia, susceptibility to, 1congenital fiber-type disproportion myopathycongenital multicore myopathy with external ophthalmoplegiaKing-Denborough syndrome
Similar variants
- RYR1 c.10347+1G>A Pathogenic ★★★ same condition
- RYR1 c.10348-6C>G Pathogenic ★★★ same condition
- RYR1 c.1925+1G>C Likely pathogenic ★★★ same condition
- RYR1 c.8310+1G>T Pathogenic ★★★ same condition
- RYR1 c.9472+1G>A Pathogenic ★★★ same condition
- RYR1 p.Ala152Asp Likely pathogenic ★★★ same condition
- RYR1 p.Ala2200Val Likely pathogenic ★★★ ⚠ same condition
- RYR1 p.Ala2437Val Likely pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ryr1-p-pro4489ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown